After several years of restructuring, Switzerland-based Clariant is looking to develop its second-generation bioethanol technology – which uses crops to create biofuel – as a direct result of its $2.5 billion buyout of Sued-Chemie. The company, purchased in 2011, focuses on catalyst making and has reportedly allowed for Clariant to utilize more advanced technology and research. The company has now announced new testing of that technology in efforts to strengthen its stance against rivals Royal DSM NV and Novosymes A/S. Testing is reportedly going on in Munich, Germany. The company is also planning to sell three of its commodity-chemical units for $1.3 billion to re-invest profits into the project. Clariant says the deals will be finalized by the end of this September.
Featured News
Trump’s Defamation Case Against New York Times Advances in Federal Court
Nov 19, 2026 by
CPI
Musk’s xAI Faces Skeptical US Judges Over California AI Disclosure Law
Nov 19, 2026 by
CPI
Italy Ends Vorwerk Antitrust Probe After Consumer Compensation Deal
Nov 19, 2026 by
CPI
Canada Wins Court Order to Advance Gap, Old Navy Advertising Probe
Nov 19, 2026 by
CPI
Russia Orders Major Retailers to Disclose Food Pricing Data in Antitrust Review
Nov 19, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Labor Market Collusion
Nov 19, 2026 by
CPI
From Price-Fixing to Wage-Fixing: Are Labor Markets the Next Frontier of Public and Private Competition Law Enforcement?
Nov 19, 2026 by
Giulia Rurali & Carsten Krüger
Damage Estimation and Labor Market Collusion
Nov 19, 2026 by
Louis D. Pape
Recent Developments of Labor Market Collusion in the EU: The Dialogue Between Delivery Hero and Tondela
Nov 19, 2026 by
Catarina Vieira Peres & Rita Ferreira Gomes
Enforcement in Labor Collusion and Monopsony: Trends and Challenges
Nov 19, 2026 by
Leyla Karakas & Anna Meyendorff